JP2013510870A5 - - Google Patents

Download PDF

Info

Publication number
JP2013510870A5
JP2013510870A5 JP2012538997A JP2012538997A JP2013510870A5 JP 2013510870 A5 JP2013510870 A5 JP 2013510870A5 JP 2012538997 A JP2012538997 A JP 2012538997A JP 2012538997 A JP2012538997 A JP 2012538997A JP 2013510870 A5 JP2013510870 A5 JP 2013510870A5
Authority
JP
Japan
Prior art keywords
methyl
pharmaceutically acceptable
acceptable salt
fluoro
chloro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2012538997A
Other languages
English (en)
Japanese (ja)
Other versions
JP5723381B2 (ja
JP2013510870A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2010/056449 external-priority patent/WO2011060217A1/en
Publication of JP2013510870A publication Critical patent/JP2013510870A/ja
Publication of JP2013510870A5 publication Critical patent/JP2013510870A5/ja
Application granted granted Critical
Publication of JP5723381B2 publication Critical patent/JP5723381B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2012538997A 2009-11-16 2010-11-12 Orl−1受容体アンタゴニストとしてのスピロピペリジン化合物 Active JP5723381B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP09382245.0 2009-11-16
EP09382245 2009-11-16
US29862810P 2010-01-27 2010-01-27
US61/298,628 2010-01-27
PCT/US2010/056449 WO2011060217A1 (en) 2009-11-16 2010-11-12 Spiropiperidine compounds as orl-1 receptor antagonists

Publications (3)

Publication Number Publication Date
JP2013510870A JP2013510870A (ja) 2013-03-28
JP2013510870A5 true JP2013510870A5 (https=) 2013-11-21
JP5723381B2 JP5723381B2 (ja) 2015-05-27

Family

ID=41800752

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012538997A Active JP5723381B2 (ja) 2009-11-16 2010-11-12 Orl−1受容体アンタゴニストとしてのスピロピペリジン化合物

Country Status (18)

Country Link
US (1) US20120214784A1 (https=)
EP (1) EP2501704B1 (https=)
JP (1) JP5723381B2 (https=)
KR (1) KR101368130B1 (https=)
CN (1) CN102666550B (https=)
AU (1) AU2010319400B2 (https=)
BR (1) BR112012011710A2 (https=)
CA (1) CA2781041C (https=)
DK (1) DK2501704T3 (https=)
EA (1) EA020391B1 (https=)
ES (1) ES2436241T3 (https=)
HR (1) HRP20130969T1 (https=)
MX (1) MX2012005690A (https=)
PL (1) PL2501704T3 (https=)
PT (1) PT2501704E (https=)
RS (1) RS53017B (https=)
SI (1) SI2501704T1 (https=)
WO (1) WO2011060217A1 (https=)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG10201510665WA (en) 2009-12-04 2016-01-28 Sunovion Pharmaceuticals Inc Multicycle Compounds And Pharmaceutical Compositions Useful For The Treatment Of Neurological Disorders
TWI582096B (zh) * 2011-12-06 2017-05-11 美國禮來大藥廠 用於酒精依賴及濫用處理之4',5'-二氫螺[哌啶-4,7'-噻吩并[2,3-c]哌喃]化合物
TW201416370A (zh) 2012-07-31 2014-05-01 Lilly Co Eli 用於治療焦慮之orl-1受體拮抗劑
US20140206667A1 (en) 2012-11-14 2014-07-24 Michela Gallagher Methods and compositions for treating schizophrenia
JO3638B1 (ar) * 2015-09-09 2020-08-27 Lilly Co Eli مركبات مفيدة في تثبيط ror - جاما- t
MA45795A (fr) 2016-07-29 2019-06-05 Sunovion Pharmaceuticals Inc Composés et compositions, et utilisations associées
PT3494119T (pt) 2016-07-29 2024-12-10 Pgi Drug Discovery Llc Compostos e composições e seus usos
ES2858093T3 (es) 2016-08-10 2021-09-29 Bayer Cropscience Ag 2-Heterociclil-imidazolil-carboxamidas sustituidas como pesticidas
MX390141B (es) 2017-02-16 2025-03-20 Sunovion Pharmaceuticals Inc Metodos para tratar esquizofrenia
US10603320B2 (en) * 2017-03-02 2020-03-31 Eli Lilly And Company Compounds useful for inhibiting ROR-gamma-t
HUE054483T2 (hu) 2017-03-02 2021-09-28 Lilly Co Eli ROR-gamma-T gátlására alkalmas vegyületek
CA3070993C (en) 2017-08-02 2025-05-20 Sunovion Pharmaceuticals Inc. ISOCHROMANE COMPOUNDS AND THEIR USES
UA130249C2 (uk) 2018-02-16 2025-12-31 Сумітомо Фарма Америка, Інк. Солі, кристалічні форми і способи їх отримання
US11618746B2 (en) 2018-12-17 2023-04-04 Vertex Pharmaceuticals Incorporated Inhibitors of APOL1 and methods of using same
EP3938045A1 (en) 2019-03-14 2022-01-19 Sunovion Pharmaceuticals Inc. Salts of a isochromanyl compound and crystalline forms, processes for preparing, therapeutic uses, and pharmaceutical compositions thereof
EP3766879A1 (en) 2019-07-19 2021-01-20 Basf Se Pesticidal pyrazole derivatives
CA3180115A1 (en) 2020-04-14 2021-10-21 Sunovion Pharmaceuticals Inc. (s)-(4,5-dihydro-7h-thieno[2,3-c]pyran-7-yl)-n-methylmethanamine for treating neurological and psychiatric disorders
CN115867543A (zh) 2020-06-12 2023-03-28 弗特克斯药品有限公司 Apol1抑制剂的固体形式及其使用方法
CN116547287B (zh) 2020-08-26 2025-09-26 弗特克斯药品有限公司 Apol1的抑制剂及其使用方法
CA3251050A1 (en) * 2022-02-08 2023-08-17 Vertex Pharmaceuticals Incorporated 2-METHYL-4',5'-DIHYDROSPIRO[PIPERIDINE-4,7'-THIENO[2,3-C]PYRAN] DERIVATIVES USED AS APOL1 INHIBITORS AND THEIR METHODS OF USE

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003095427A1 (en) 2002-05-10 2003-11-20 Taisho Pharmaceutical Co.,Ltd. Spiro-ring compound
WO2005016913A1 (en) * 2003-08-19 2005-02-24 Pfizer Japan, Inc. Tetrahydroisoquinoline or isochroman compounds as orl-1 receptor ligands for the treatment of pain and cns disorders
DE10360792A1 (de) * 2003-12-23 2005-07-28 Grünenthal GmbH Spirocyclische Cyclohexan-Derivate
US7354925B2 (en) * 2004-03-29 2008-04-08 Pfizer Inc. Alpha aryl or heteroaryl methyl beta piperidino propanamide compounds as ORL1-receptor antagonists
DE102004039382A1 (de) * 2004-08-13 2006-02-23 Grünenthal GmbH Spirocyclische Cyclohexan-Derivate
WO2006130416A2 (en) * 2005-06-02 2006-12-07 Janssen Pharmaceutica, N.V. Novel 3-spirocyclic indolyl derivatives useful as orl-1 receptor modulators

Similar Documents

Publication Publication Date Title
JP2013510870A5 (https=)
JP2013510859A5 (https=)
HRP20130969T1 (hr) Spojevi spiropiperidona kao antagonisti receptora orl-1
JP6424219B2 (ja) 複素芳香環−ベンジル−アミド−サイクルコアを含むオートタキシン阻害剤
JP6572294B2 (ja) 殺菌・殺カビ性アゾ環式アミド
CA2699933C (en) Fungicidal mixtures
HRP20130967T1 (hr) Spojevi spiropiperidona kao antagonisti receptora orl-1
ES2568882T3 (es) Derivado de azol
ME01462B (me) Vinilindazolilna jedinjenja"
JP2013517281A5 (https=)
JP2016535772A5 (https=)
WO2013042138A3 (en) Process for preparation of triazole antifungal drug, its intermediates and polymorphs thereof
JP2016519156A5 (https=)
RU2016102647A (ru) Ингибиторы бромодомена
JP2014051531A (ja) JANUSキナーゼ阻害剤としてのヘテロアリール置換ピロロ[2,3−b]ピリジンおよびピロロ[2,3−b]ピリミジン
JP2013532709A5 (https=)
BRPI0807014A2 (pt) Composto, pró-droga, agente farmacêutico, métodos para melhorar a resistência a insulina em um mamífero, método para a profilaxia ou o tratamento de diabetes em um mamífero, e, uso de um composto.
JP2008513500A5 (https=)
AR072201A1 (es) 2-arilaminoquinazolinas para el tratamiento de enfermedades proliferativas
RU2010147925A (ru) 1-арил-3-аминоалкоксипиразолы как сигма-лиганды, усиливающие обезболивающее действие опиоидов и ослабляющие зависимость от них
JP2014501732A5 (https=)
RU2017107506A (ru) Конденсированные 11-членные соединения и содержащие их сельскохозяйственные/садоводческие фунгициды
RU2015148766A (ru) Комбинации лигандов альфа-2 адренорецептора и сигма рецептора
RU2019123319A (ru) Пиразолопиримидины и способы их применения
CN109790158A (zh) 作为jak抑制剂杂环化合物,该化合物的盐类及其治疗用途